TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15186658

Group type: EXPERIMENTAL
Intervention: Lifestyle change intervention
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Lifestyle change with self-control skills intervention
Number of subjects: 44

Group type: COMPARATOR
Intervention: 1-year follow-up
Number of subjects: 44
Study: 12494285

Group type: EXPERIMENTAL
Intervention: Transdermal needle-free injection of alprostadil
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intracavernosal needle injections of alprostadil
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Needle-free injection
Number of subjects: 8

Group type: COMPARATOR
Intervention: Needle-tipped injection
Number of subjects: 8
Study: 9819795

Group type: EXPERIMENTAL
Intervention: Group 1: Cytosine arabinoside (Ara‐C) (100 mg/m2/d, days 1‐7) and idarubicin (Ida) (12 mg/m2/d, days 1‐3) for induction; Ara‐C (200 mg/m2/d, days 1‐6) and Ida (15 mg/m2/d, day 1) twice for consolidation.
Number of subjects: 99

Group type: COMPARATOR
Intervention: Group 2: Ara‐C (200 mg/m2/d, days 1‐10), daunorubicin (Dnc) (50 mg/m2/d, days 1, 3, 5) and etoposide (VP16) (100 mg/m2/d, days 1‐5) for induction; consolidation therapy with Ara‐C on days 1‐8 and additional regimens.
Number of subjects: 99

Group type: COMPARATOR
Intervention: Group 3: Identical to Group 1 except for Ida replaced with Mitox.
Number of subjects: 99
Study: 8086025

Group type: EXPERIMENTAL
Intervention: 10 ml of 0.5% bupivacaine
Number of subjects: 48

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 48
Study: 2756086

Group type: EXPERIMENTAL
Intervention: High stress condition (Type A students)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Low stress condition (Type A students)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: High stress condition (Type A community women)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Low stress condition (Type A community women)
Number of subjects: 99
Study: 331941

Group type: EXPERIMENTAL
Intervention: Triple dye
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Castile soap
Number of subjects: 3
Study: 30690854

Group type: EXPERIMENTAL
Intervention: NA-STEMI patients undergoing PCI
Number of subjects: 1495

Group type: EXPERIMENTAL
Intervention: Risk factors for NA-STEMI patients
Number of subjects: 1495
Study: 29175466

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with 0.01% Methylene Blue and red laser, λ660 nm, 3J energy per point
Number of subjects: 29

Group type: COMPARATOR
Intervention: Low level laser therapy (LLLT) with λ660 nm, 1J energy per point
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both PDT and LLLT
Number of subjects: 29
Study: 26966058

Group type: EXPERIMENTAL
Intervention: Tianjiu therapy applied at three points (conception vessel 4, and bilateral kidney 1) during each HD session for 4 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clay patches applied in the same way as those in the Tianjiu treatment group for 4 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tianjiu therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clay patches
Number of subjects: 0
Study: 24388635

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 59

Group type: COMPARATOR
Intervention: Lindeman bur and chisel (Control)
Number of subjects: 59
Study: 21827501

Group type: EXPERIMENTAL
Intervention: Single Target Implicit Association Test (ST-IAT) - Image version
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Single Target Implicit Association Test (ST-IAT) - Word version
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Self-report measures of blood donation attitudes
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Self-report measures of blood and needle fears
Number of subjects: 253
Study: 19926782

Group type: EXPERIMENTAL
Intervention: rosiglitazone (4 mg/day for 6 weeks followed by 8 mg/day for 6 weeks)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: rosiglitazone
Number of subjects: 23
Study: 17351377

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 53

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 53
Study: 15846970

Group type: EXPERIMENTAL
Intervention: Claims-driven decision support system
Number of subjects: 0
Study: 11846190

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 9972764

Group type: EXPERIMENTAL
Intervention: Pressure palpator
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pinprick
Number of subjects: 50
Study: 7562885

Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg for 1 month, 20 mg for 1 month, 40 mg for 4 months (once daily in the evening)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 50
Study: 2196107

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with methotrexate, cisplatin, and continuous infusion 5-fluorouracil (MPF) (arm A)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with bleomycin, cisplatin, and methotrexate (PBM) alternating with cisplatin and 5-FU (PF) (arm B)
Number of subjects: 42
Study: 322269

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control period
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison between Ketoprofen and Naproxen
Number of subjects: 12
Study: 31393397

Group type: EXPERIMENTAL
Intervention: Thread Embedding Acupuncture (TEA)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Physical Therapy (PT)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: TEA
Number of subjects: 128

Group type: COMPARATOR
Intervention: PT
Number of subjects: 128
Study: 29085049

Group type: EXPERIMENTAL
Intervention: Ceftiofur crystalline‐free acid (CCFA)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Chlortetracycline
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control (no treatment specified)
Number of subjects: 176
Study: 24898613

Group type: EXPERIMENTAL
Intervention: $10 gift cards after mental health visits
Number of subjects: 42

Group type: COMPARATOR
Intervention: No financial incentives (control group)
Number of subjects: 42
Study: 23786763

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) with MoodGYM
Number of subjects: 14
Study: 21303218

Group type: EXPERIMENTAL
Intervention: Standard protocol of aerobic physical activity: 150 min of moderate intensity aerobic activity per week
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (20 patients with vascular ED who did not undergo aerobic physical activity)
Number of subjects: 50
Study: 19809326

Group type: EXPERIMENTAL
Intervention: Amiodarone (150 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (Isotonic saline)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lidocaine (100 mg)
Number of subjects: 120
Study: 16470128

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 or 80 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 15195758

Group type: EXPERIMENTAL
Intervention: Extensive BMV hemispheres
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diminished BMV hemispheres
Number of subjects: 16

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 16
Study: 11131620

Group type: EXPERIMENTAL
Intervention: Horizontally oriented histograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vertically oriented histograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pie charts
Number of subjects: 0
Study: 9321533

Group type: EXPERIMENTAL
Intervention: Enforcement of tobacco-sales laws in three communities (intervention group)
Number of subjects: 22021

Group type: COMPARATOR
Intervention: No enforcement of tobacco-sales laws in three matched communities (control group)
Number of subjects: 22021
Study: 8423275

Group type: EXPERIMENTAL
Intervention: Intranasal beclomethasone dipropionate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3528223

Group type: EXPERIMENTAL
Intervention: 10 mg folic acid daily
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 29722833

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (2.3 g daily)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo (low-polyphenolic olive oil)
Number of subjects: 403
Study: 27168163

Group type: EXPERIMENTAL
Intervention: 1% phenoxyethanol
Number of subjects: 243

Group type: COMPARATOR
Intervention: TRPV1 antagonist ID1609
Number of subjects: 243
Study: 26387418

Group type: EXPERIMENTAL
Intervention: Thai massage applied on the lower back and lower limbs for 30 minutes.
Number of subjects: 17
Study: 22524327

Group type: EXPERIMENTAL
Intervention: Modified Widman flap surgery with diode laser (810 nm)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Modified Widman flap surgery alone
Number of subjects: 13
Study: 21426752

Group type: EXPERIMENTAL
Intervention: Stenotic microvasculopathy
Number of subjects: 64
Study: 18202561

Group type: EXPERIMENTAL
Intervention: Psychological skills training (PST)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 18
Study: 17628127

Group type: EXPERIMENTAL
Intervention: Periodic health evaluation (PHE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Scheduling of appointments for PHE
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Offering a free PHE
Number of subjects: 36
Study: 15580719

Group type: EXPERIMENTAL
Intervention: Atrial based pacing
Number of subjects: 73

Group type: COMPARATOR
Intervention: VVI(R) pacing
Number of subjects: 73
Study: 10674597

Group type: COMPARATOR
Intervention: Formula company-produced materials (commercial; n = 277)
Number of subjects: 547
Study: 9114206

Group type: EXPERIMENTAL
Intervention: Sulbactam/cefoperazone (2-4 g/d) administered in evenly divided doses every 12 hours by a 30-minute intravenous drip
Number of subjects: 235

Group type: COMPARATOR
Intervention: Cefotaxime (6-12 g/d) administered in evenly divided doses every 6 or 8 hours by a 30-minute intravenous drip
Number of subjects: 235
Study: 8404241

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3513083

Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30281805

Group type: EXPERIMENTAL
Intervention: Oral oestradiol (2 mg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transdermal oestradiol (100 µg/d)
Number of subjects: 40
Study: 30195946

Group type: EXPERIMENTAL
Intervention: Phenylephrine 0.25%
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Oxymetazoline 0.05%
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% with epinephrine 1:100,000
Number of subjects: 68

Group type: COMPARATOR
Intervention: Saline (bacteriostatic 0.9% sodium chloride)
Number of subjects: 68
Study: 27765686

Group type: EXPERIMENTAL
Intervention: 10% sucralfate ointment (every 12 hours)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 23205666

Group type: EXPERIMENTAL
Intervention: Intensive vascular risk factor intervention
Number of subjects: 195

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 195
Study: 22741944

Group type: EXPERIMENTAL
Intervention: Methadone induction in primary care (n = 147)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Methadone induction in CSAPA (n = 48)
Number of subjects: 195
Study: 20049522

Group type: EXPERIMENTAL
Intervention: Non-woven textile material (modified tampon) for vaginal drug delivery
Number of subjects: 47
Study: 18652727

Group type: EXPERIMENTAL
Intervention: Waiting room video
Number of subjects: 1132
Study: 15798411

Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 91

Group type: COMPARATOR
Intervention: Plain lubricant
Number of subjects: 91
Study: 12453372

Group type: EXPERIMENTAL
Intervention: Levofloxacin (Group 1)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Amoxicillin or clarithromycin (Group 2)
Number of subjects: 125
Study: 11188778

Group type: EXPERIMENTAL
Intervention: IVIG (intravenous immunoglobulin) 0.15-0.2 g/kg bodyweight monthly for 2 years
Number of subjects: 148
Study: 9093096

Group type: EXPERIMENTAL
Intervention: Screening for breast cancer (mammography)
Number of subjects: 158755

Group type: COMPARATOR
Intervention: Control group (not invited to screening)
Number of subjects: 158755

Group type: EXPERIMENTAL
Intervention: Screening for breast cancer (mammography) among women aged under 56 years
Number of subjects: 158755
Study: 8244414

Group type: EXPERIMENTAL
Intervention: 4 cm handle span
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 7 cm handle span
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Extended trigger
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Increasing handle span from 4 cm to 7 cm
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Handle span preference
Number of subjects: 18
Study: 3326525

Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ketoconazole 800 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ketoconazole 1200 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ketoconazole 1600 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ketoconazole (various doses)
Number of subjects: 160
Study: 31711306

Group type: EXPERIMENTAL
Intervention: Experimental therapy (50% efficacious)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control therapy (80% efficacious)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed enrollment strategy (TST and IGRA)
Number of subjects: 0
Study: 29659178

Group type: EXPERIMENTAL
Intervention: 60 mg of botanically sourced caffeine from 480 mg of green coffee bean extract
Number of subjects: 16

Group type: COMPARATOR
Intervention: 60 mg of synthetic USP caffeine
Number of subjects: 16
Study: 27999162

Group type: EXPERIMENTAL
Intervention: Heterologous fecal microbiota transplantation (FMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Autologous fecal microbiota transplantation (FMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heterologous FMT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Autologous FMT
Number of subjects: 0
Study: 24930044

Group type: EXPERIMENTAL
Intervention: Intracoronary autologous bone marrow stem cell (mBMC) transplantation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Patients with AMI
Number of subjects: 30

Group type: COMPARATOR
Intervention: Patients with stable angina pectoris (AP)
Number of subjects: 30
Study: 22840731

Group type: EXPERIMENTAL
Intervention: Experimental group (hip extensor fatigue)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham control group (push-ups to exhaustion)
Number of subjects: 40
Study: 20096510

Group type: EXPERIMENTAL
Intervention: Extended cognitive behavioral treatment
Number of subjects: 199

Group type: COMPARATOR
Intervention: Standard Treatment
Number of subjects: 199
Study: 18724004

Group type: EXPERIMENTAL
Intervention: Dried-bonito broth
Number of subjects: 159
Study: 16050395

Group type: EXPERIMENTAL
Intervention: Conventional hemodialysis (three sessions per week through a low‐flux membrane)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal dialysis strategies (not specified)
Number of subjects: 0
Study: 12878335

Group type: COMPARATOR
Intervention: Usual nutritional rehabilitation program
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Usual nutritional rehabilitation program + 5 g x d(‐1) of spiruline
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Usual nutritional rehabilitation program + spiruline + fish
Number of subjects: 165
Study: 10376262

Group type: EXPERIMENTAL
Intervention: 1 mg midazolam
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 8888911

Group type: EXPERIMENTAL
Intervention: Infant formula with higher TRP content (2.10%)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Infant formula with moderate TRP content (1.88%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Breastfed control group (11 infants)
Number of subjects: 20
Study: 1858500

Group type: EXPERIMENTAL
Intervention: Topically applied vaginal tablet of 150 mg econazole
Number of subjects: 235

Group type: COMPARATOR
Intervention: Orally administered capsule of 150 mg fluconazole
Number of subjects: 235
Study: 31152288

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy (PPT)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study: 27548791

Group type: EXPERIMENTAL
Intervention: Linear periodized strength training (ST) program
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no strength training)
Number of subjects: 31
Study: 26005814

Group type: EXPERIMENTAL
Intervention: Resistance training program of high intensity and low volume for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 23218945

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 4539
Study: 21235716

Group type: EXPERIMENTAL
Intervention: Sildenafil for 12 weeks
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 115
Study: 19942723

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Steroid
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control (conventional expectant treatment)
Number of subjects: 119
Study: 17279843

Group type: EXPERIMENTAL
Intervention: Goal priming with negative affect coactivation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Goal priming without negative affect
Number of subjects: 0
Study: 15036798

Group type: EXPERIMENTAL
Intervention: Cyclosporine plus chloroquine (CsA/Clq)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Cyclosporine plus placebo (CsA/Plac)
Number of subjects: 149
Study: 11277160

Group type: EXPERIMENTAL
Intervention: Training and implementation of evidence-based clinical practice guideline for neonatal skin care
Number of subjects: 2820

Group type: EXPERIMENTAL
Intervention: Implementation of project-designed tools and guidelines
Number of subjects: 2820

Group type: EXPERIMENTAL
Intervention: Guideline implementation
Number of subjects: 2820
Study: 9834926

Group type: EXPERIMENTAL
Intervention: High-complex-carbohydrate, low-fat formulation (HCF)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Low-carbohydrate formulation (RCF)
Number of subjects: 52
Study: 7915963

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 14
Study: 2668099

Group type: EXPERIMENTAL
Intervention: Standard biopsy forceps
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Jumbo biopsy forceps
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Biopsy from different locations (second, third, fourth portions of the duodenum, ligament of Treitz, jejunum)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Biopsy from different locations
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Biopsy
Number of subjects: 26
Study: 326048

Group type: EXPERIMENTAL
Intervention: Carbenicillin plus cephalothin
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Carbenicillin plus cefazolin
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Carbenicillin
Number of subjects: 334

Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 334
Study: 31599079

Group type: EXPERIMENTAL
Intervention: 6-min step test (6MST)
Number of subjects: 35
Study: 30769164

Group type: EXPERIMENTAL
Intervention: Z-scan technique with selenium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Z-scan technique without selenium supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spectrophotometry technique with selenium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spectrophotometry technique without selenium supplementation
Number of subjects: 0
Study: 28835713

Group type: EXPERIMENTAL
Intervention: NγLR > 103.6
Number of subjects: 724

Group type: COMPARATOR
Intervention: NγLR ≤ 103.6
Number of subjects: 724
Study: 24667592

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299 v (5 × 10 colony forming units daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299 v
Number of subjects: 0
Study: 23218847

Group type: EXPERIMENTAL
Intervention: TAU plus web-delivered BAI
Number of subjects: 167

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 167
Study: 21516002

Group type: EXPERIMENTAL
Intervention: Community health promotion project for garlic farmers (12 weeks)
Number of subjects: 72
Study: 18083636

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 6241
Study: 16966226

Group type: EXPERIMENTAL
Intervention: Creativity enhancement intervention
Number of subjects: 0
Study: 12767649

Group type: EXPERIMENTAL
Intervention: Atrioventricular junction ablation and pacing (AVJAP)
Number of subjects: 99
Study: 10697086

Group type: EXPERIMENTAL
Intervention: Psychosocial support program during early rehabilitation
Number of subjects: 151
Study: 9088734

Group type: EXPERIMENTAL
Intervention: levobunolol HCl 0.5%
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study: 8251030

Group type: EXPERIMENTAL
Intervention: Granisetron (40 micrograms/kg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional antiemetics
Number of subjects: 17
Study: 3810557

Group type: EXPERIMENTAL
Intervention: LMWH 1 (1000, 1500, 2500 i.u.)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LMWH 1 (2500 i.u.)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LMWH 2 (2500 i.u.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: UFH (5000 i.u.)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All heparins tested
Number of subjects: 24
Study: 28314876

Group type: EXPERIMENTAL
Intervention: Remote ischemic postconditioning (RIPC) with three cycles of 5-min cuff inflation followed by 5-min deflation to the upper arm
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no RIPC)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Remote ischemic postconditioning (RIPC)
Number of subjects: 78
Study: 27706045

Group type: EXPERIMENTAL
Intervention: Erythropoietin (33,000 IU IV daily for three days)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 35